We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock

Delisted

DCPH was delisted on the 10th of June, 2024.

1 hedge funds and large institutions have $759K invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 174 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1771 (-176)

100% less capital invested

Capital invested by funds: $944M → $759K (-$943M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 174

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
174
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
-$19.5K -1,241 Closed
Pacer Advisors
152
Pacer Advisors
Pennsylvania
-$16K -1,016 Closed
TAM
153
Tucker Asset Management
Colorado
-$15.7K -1,000 Closed
PD
154
Point72 (DIFC)
United Arab Emirates
-$12.9K -818 Closed
Group One Trading
155
Group One Trading
Illinois
-$11.1K -705 Closed
HNB
156
Huntington National Bank
Ohio
-$10.3K -653 Closed
PNC Financial Services Group
157
PNC Financial Services Group
Pennsylvania
-$9.42K -599 Closed
NS
158
NBC Securities
Alabama
-$9K -586 Closed
Simplex Trading
159
Simplex Trading
Illinois
-$8K -519 Closed
MIM
160
Macroview Investment Management
Maryland
-$7.99K -508 Closed
LC
161
Lindbrook Capital
California
-$7.25K -461 Closed
HIM
162
Hillsdale Investment Management
Ontario, Canada
-$6.29K -400 Closed
Comerica Bank
163
Comerica Bank
Texas
-$4.55K -289 Closed
Daiwa Securities Group
164
Daiwa Securities Group
Japan
-$4K -272 Closed
AWM
165
Avior Wealth Management
Nebraska
-$3.67K -233 Closed
GI
166
GAMMA Investing
California
-$2.25K -143 Closed
LFG
167
Larson Financial Group
Missouri
-$1.95K -124 Closed
CAL
168
Capital Advisors Ltd
Ohio
-$2K -117 Closed
GRP
169
Global Retirement Partners
California
-$1.57K -100 Closed
Carson Wealth (CWM LLC)
170
Carson Wealth (CWM LLC)
Nebraska
-$1K -83 Closed
FFA
171
Farther Finance Advisors
California
-$1.17K -74 Closed
PA
172
Parallel Advisors
California
-$975 -62 Closed
FHA
173
First Horizon Advisors
Tennessee
-$471 -30 Closed
RIL
174
Rothschild Investment LLC
Illinois
-$157 -10 Closed

DCPH Hedge Fund Activity: Q2 2024 in Review

1 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2024, worth a combined $759K — down 100% from $944M a quarter earlier.

Sellers outnumbered buyers: 174 funds closed out of DCPH and 0 opened new positions — a net loss of 174 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $94.3M sold.

  • 1 institutional investor held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2024, down from 177 in Q1 2024.
  • Funds reported $759K of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 174 closed out, a net change of -174 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $94.3M sold.

Based on aggregated 13F filings for Q2 2024.